Skip to main content
Livermore
Livermore
ZHEN

Exome Asset Management LLC

SEC CIK
0002011932
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Oct 3, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
52
−1 vs. Q1 2024
Portfolio value
$112.3M
−$4.46M (−3.8%) vs. Q1 2024
Filed
Oct 3, 2024
AmendedSEC
Holdings of Exome Asset Management LLC in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
LLYEli Lilly & CoStock9,700$8.78M7.8%00.0%UnchangedHistory
SRPTSarepta Therapeutics, Inc.COM32,900$5.20M4.6%+32,900NewHistory
ONCBeOne Medicines Ltd.ADR33,200$4.74M4.2%−3,600−9.8%ReducedHistory
TGTXTG Therapeutics, Inc.COM251,600$4.48M4.0%+21,300+9.2%AddedHistory
CICigna GroupStock12,200$4.03M3.6%−3,100−20.3%ReducedHistory
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW84,790$3.84M3.4%−3,056−3.5%ReducedHistory
INSMINSMED IncCOM PAR $.0156,800$3.81M3.4%−14,900−20.8%ReducedHistory
AMGNAmgen IncStock11,800$3.69M3.3%+11,800NewHistory
TVTXTravere Therapeutics, Inc.COM443,379$3.64M3.2%+80,892+22.3%AddedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM10,800$3.03M2.7%+2,900+36.7%AddedHistory
AVDLAvadel Pharmaceuticals PLCStock209,092$2.94M2.6%+209,092NewHistory
DXCMDexcom IncCOM25,928$2.94M2.6%+1,100+4.4%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS839,472$2.92M2.6%+839,472NewHistory
ISRGIntuitive Surgical IncCOM NEW6,358$2.83M2.5%00.0%UnchangedHistory
RDYDr Reddys Laboratories LtdADR36,300$2.77M2.5%−49,700−57.8%ReducedHistory
IRONDisc Medicine, Inc.COM61,000$2.75M2.4%+61,000NewHistory
ASNDAscendis Pharma A/SSPONSORED ADR20,000$2.73M2.4%+20,000NewHistory
KURAKura Oncology, Inc.COM131,742$2.71M2.4%+131,742NewHistory
MRUSMerus N.V.COM45,100$2.67M2.4%+45,100NewHistory
MASIMasimo CorpCOM19,800$2.49M2.2%+19,800NewHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS274,900$2.48M2.2%00.0%UnchangedHistory
WVEWave Life Sciences, Inc.SHS488,135$2.44M2.2%+488,135NewHistory
GHGuardant Health, Inc.COM79,000$2.28M2.0%00.0%UnchangedHistory
CABACabaletta Bio, Inc.COM300,200$2.25M2.0%+300,200NewHistory
ARVNArvinas, Inc.COM82,400$2.19M2.0%+82,400NewHistory
NTRANatera, Inc.COM18,650$2.02M1.8%00.0%UnchangedHistory
BHVNBiohaven Ltd.COM57,800$2.01M1.8%+57,800NewHistory
BBIOBridgeBio Pharma, Inc.COM78,907$2.00M1.8%+30,100+61.7%AddedHistory
FULCFulcrum Therapeutics, Inc.COM302,700$1.88M1.7%+302,700NewHistory
APLSApellis Pharmaceuticals, Inc.COM46,900$1.80M1.6%+46,900NewHistory
ATECAlphatec Holdings, Inc.COM NEW162,100$1.69M1.5%+162,100NewHistory
ABCLAbCellera Biologics Inc.COM514,900$1.52M1.4%+514,900NewHistory
ZLABZai Lab LtdADR86,700$1.50M1.3%+21,400+32.8%AddedHistory
PLRXPliant Therapeutics, Inc.COM124,000$1.33M1.2%+124,000NewHistory
RZLTRezolute, Inc.COM NEW282,400$1.21M1.1%+282,400NewHistory
ALVOAlvotechORDINARY SHARES99,000$1.20M1.1%+99,000NewHistory
GOSSGossamer Bio, Inc.COM1,127,699$1.02M0.9%+1,127,699NewHistory
ELEVElevation Acquisition Group Inc.COM369,322$997.2K0.9%00.0%UnchangedHistory
ESTAEstablishment Labs Holdings Inc.COM21,700$986.0K0.9%+21,700NewHistory
SYRSSyros Pharmaceuticals, Inc.COM NEW159,175$821.3K0.7%+159,175NewHistory
QTRXQuanterix CorpCOM59,650$788.0K0.7%00.0%UnchangedHistory
QTTBQ32 Bio Inc.COM43,865$787.4K0.7%−21,156−32.5%ReducedHistory
YARWYarrow Bioscience, Inc.COM353,434$696.3K0.6%−62,000−14.9%ReducedHistory
PMVPPMV Pharmaceuticals, Inc.COM358,400$580.6K0.5%+358,400NewHistory
APREAprea Therapeutics, Inc.COM NEW137,174$558.3K0.5%+137,174NewHistory
TECXTectonic Therapeutic, Inc.COM32,389$533.4K0.5%+27,294+535.8%AddedConverted for a 1-for-12 splitHistory
ADAGAdagene Inc.ADS150,876$461.8K0.4%−4,507−2.9%ReducedHistory
NBPNovaBridge BiosciencesSPONSORED ADS271,400$453.2K0.4%−54,362−16.7%ReducedHistory
Procaps Group S AL7756P102SHS126,901$321.1K0.3%+126,901New–
HLVXHilleVax, Inc.COM18,000$260.3K0.2%+18,000NewHistory
SGMTSagimet Biosciences Inc.COM SER A50,700$173.4K0.2%−10,200−16.7%ReducedHistory
PACBPacific Biosciences of California, Inc.COM75,300$103.2K0.1%00.0%UnchangedHistory

Sold out since Q1 2024 (28)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Exome Asset Management LLC sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
ALPNAlpine Immune Sciences, Inc.COM117,000$4.64M4.0%History
Avidity Biosciences, Inc.05370A108COM135,169$3.45M3.0%–
CLDXCelldex Therapeutics, Inc.COM NEW71,100$2.98M2.6%History
GERNGeron CorpCOM886,800$2.93M2.5%History
JBIOJade Biosciences, Inc.COM98,485$2.91M2.5%History
Morphosys AG617760202SPONSORED ADS154,800$2.81M2.4%–
KRYSKrystal Biotech, Inc.COM14,700$2.62M2.2%History
TARSTarsus Pharmaceuticals, Inc.COM66,300$2.41M2.1%History
INZYInozyme Pharma, Inc.COM273,413$2.09M1.8%History
RYTMRhythm Pharmaceuticals, Inc.COM45,603$1.98M1.7%History
EXASExact Sciences CorpCOM26,700$1.84M1.6%History
CYTKCytokinetics IncCOM NEW26,008$1.82M1.6%History
RGNXREGENXBIO Inc.COM84,470$1.78M1.5%History
BIIBBiogen Inc.COM8,200$1.77M1.5%History
OCULOcular Therapeutix, IncCOM193,600$1.76M1.5%History
AGIOAgios Pharmaceuticals, Inc.COM59,902$1.75M1.5%History
PENPenumbra IncCOM7,353$1.64M1.4%History
OLMAOlema Pharmaceuticals, Inc.COM143,400$1.62M1.4%History
ARWRArrowhead Pharmaceuticals, Inc.COM55,700$1.59M1.4%History
TERNTerns Pharmaceuticals, Inc.COM227,821$1.49M1.3%History
MRNSMarinus Pharmaceuticals, Inc.COM NEW163,100$1.47M1.3%History
NARIInari Medical, Inc.Stock30,100$1.44M1.2%History
ITCIIntra-Cellular Therapies, Inc.COM20,300$1.40M1.2%History
SWAVShockwave Medical, Inc.COM4,000$1.30M1.1%History
RGLSRegulus Therapeutics Inc.COM402,504$1.16M1.0%History
ELVNEnliven Therapeutics, Inc.COM57,635$1.01M0.9%History
VTYXVentyx Biosciences, Inc.COM163,922$901.6K0.8%History
RAREUltragenyx Pharmaceutical Inc.COM17,800$831.1K0.7%History